Cipher Pharmaceuticals Inc.

Informe acción TSX:CPH

Capitalización de mercado: CA$374.9m

Salud financiera de hoja de balance de Cipher Pharmaceuticals

Salud financiera controles de criterios 4/6

Cipher Pharmaceuticals tiene un patrimonio de accionistas total de $98.9M y una deuda total de $40.0M, lo que sitúa su ratio deuda-patrimonio en 40.5%. Sus activos y pasivos totales son $153.9M y $55.0M respectivamente. El BAIT de Cipher Pharmaceuticals es de $9.9M, por lo que su ratio de cobertura de intereses es de -6.9. Tiene efectivo e inversiones a corto plazo que ascienden a $9.5M.

Información clave

40.5%

Ratio deuda-patrimonio

US$40.00m

Deuda

Ratio de cobertura de intereses-6.9x
EfectivoUS$9.52m
PatrimonioUS$98.86m
Total pasivoUS$55.00m
Activos totalesUS$153.86m

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

Nov 14
Cipher Pharmaceuticals' (TSE:CPH) Anemic Earnings Might Be Worse Than You Think

With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Nov 12
With A 29% Price Drop For Cipher Pharmaceuticals Inc. (TSE:CPH) You'll Still Get What You Pay For

Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Nov 09
Cipher Pharmaceuticals Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Mar 23
There's No Escaping Cipher Pharmaceuticals Inc.'s (TSE:CPH) Muted Earnings Despite A 26% Share Price Rise

Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Mar 22
Weak Statutory Earnings May Not Tell The Whole Story For Cipher Pharmaceuticals (TSE:CPH)

Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

May 14
Here's Why I Think Cipher Pharmaceuticals (TSE:CPH) Is An Interesting Stock

Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

May 18
Analysts Just Published A Bright New Outlook For Cipher Pharmaceuticals Inc.'s (TSE:CPH)

Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Mar 20
Cipher Pharmaceuticals Inc. Just Missed EPS By 37%: Here's What Analysts Think Will Happen Next

Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Jan 26
Industry Analysts Just Upgraded Their Cipher Pharmaceuticals Inc. (TSE:CPH) Revenue Forecasts By 12%

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($29.1M) de CPH superan a sus pasivos a corto plazo ($14.5M).

Pasivo a largo plazo: Los activos a corto plazo ($29.1M) de CPH no cubren sus pasivos a largo plazo ($40.5M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: El ratio deuda neta-patrimonio (30.8%) de CPH se considera satisfactorio.

Reducción de la deuda: El ratio deuda-patrimonio de CPH ha crecido de 38.6% a 40.5% en los últimos 5 años.

Cobertura de la deuda: La deuda de CPH está bien cubierta por el flujo de caja operativo (32.7%).

Cobertura de intereses: CPH gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.


Hoja de balance


Descubre empresas con salud financiera